These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 524148)

  • 21. Markers for the factor VIII antibody response in hemophilia A.
    Shapiro SS
    Scand J Haematol Suppl; 1984; 40():181-5. PubMed ID: 6433450
    [No Abstract]   [Full Text] [Related]  

  • 22. The management of haemophiliacs who have antibodies to factor VIII.
    Rizza CR
    Scand J Haematol Suppl; 1984; 40():187-93. PubMed ID: 6433451
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of hemophilia complicated by inhibitors.
    Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
    Monahan PE; Aledort LM;
    Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming factor VIII inhibitors: a possible new approach.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Scand J Haematol Suppl; 1984; 40():207-12. PubMed ID: 6433453
    [No Abstract]   [Full Text] [Related]  

  • 27. Human anti-mouse immunoglobulins in sera of patients treated chronically with monoclonal antibody-purified factor VIII.
    Haimovich J; Davis HM; Schreiber AB
    Semin Hematol; 1990 Apr; 27(2 Suppl 2):11-5. PubMed ID: 2128852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
    White GC; Greenwood R; Escobar M; Frelinger JA
    Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The suppression of factor VIII antibodies in haemophilia.
    Dormandy KM; Sultan Y
    Pathol Biol (Paris); 1975 Dec; 23 suppl():17-23. PubMed ID: 772555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T; Skopál J; Csáki C; Laczkó M; Schuler D; Borsi J
    Orv Hetil; 1993 Dec; 134(52):2873-5. PubMed ID: 8272354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of coagulation factor VIII inhibitors].
    Lutze G; Schlote A; Mittler U
    Z Gesamte Inn Med; 1980 Apr; 35(8):330-6. PubMed ID: 6776700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 33. Proteolytic antibodies against factor VIII in hemophilia A.
    Stollar BD
    N Engl J Med; 2002 Feb; 346(9):702-3. PubMed ID: 11870249
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention and treatment of induced antibodies to clotting factors in hemophilia--applications of advances in immunology.
    Steinberg AD
    Prog Clin Biol Res; 1984; 150():155-66. PubMed ID: 6431424
    [No Abstract]   [Full Text] [Related]  

  • 35. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG subclass changes in response to replacement therapy with clotting factor VIII.
    Shakib F
    Monogr Allergy; 1986; 19():262-5. PubMed ID: 3093849
    [No Abstract]   [Full Text] [Related]  

  • 37. The development and characterisation of antibodies to human factor VIII in haemophilic dogs.
    Littlewood JD; Barrowcliffe TW
    Thromb Haemost; 1987 Jun; 57(3):314-21. PubMed ID: 3116702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated ppsb in the treatment of a patient with haemophilia and antibodies to factor VIII.
    Ekert H; McVeagh P
    Med J Aust; 1975 Oct; 2(17):675-7. PubMed ID: 1207551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of immune tolerance with factor VIII concentrate in patients with hemophilia A and inhibitors.
    Ewing NP
    Prog Clin Biol Res; 1990; 324():59-68. PubMed ID: 2106693
    [No Abstract]   [Full Text] [Related]  

  • 40. Factor VIII inhibitory antibody in a patient with combined factor V/factor VIII deficiency.
    Buckner TW; Nielsen BI; Key NS; Ma A
    Haemophilia; 2015 Jan; 21(1):e77-80. PubMed ID: 25472918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.